Literature DB >> 1331160

Blocking ELISA for distinguishing infectious bovine rhinotracheitis virus (IBRV)-infected animals from those vaccinated with a gene-deleted marker vaccine.

S Kit1, H Otsuka, M Kit.   

Abstract

A sensitive and specific blocking enzyme-linked immunosorbent assay (ELISA) was developed to distinguish infectious bovine rhinotracheitis virus (IBRV)-infected animals from those immunized with a glycoprotein gIII deletion mutant, IBRV(NG)dltkdlgIII. For this ELISA, undiluted test sera are used to block the binding of an anti-IBRV gIII monoclonal antibody (mAbgIII)-horseradish peroxidase (HRPO) conjugate to gIII antigen. TMB substrate is used for color development. Negative S/N values (defined as the absorbance at 650 nm of test sera/absorbance at 650 nm of negative control sera) of > 0.80 were obtained with immune sera from gnotobiotic cattle immunized with several bovine viruses, with bovine antisera to bovine herpesvirus-2, and vesicular stomatitis virus, with porcine antisera to pseudorabies virus and parvovirus, and with normal sera from heterologous species. Negative S/N values were also obtained with sera from rabbits twice vaccinated with IBRV(NG)dltkdlgIII. However, the S/N values became positive (S/N < 0.8) 10 to 17 days after the rabbits were challenge exposed to virulent IBRV(Cooper). Most of 116 sera (84%) from feedlot cattle with virus neutralization (VN) titers of < 1:2 or < 1:4 had negative S/N values > 0.8, but 18 sera with negative VN titers had positive S/N values, consistent with observations indicating that an IBRV outbreak was occurring in one of the feedlot herds. Thirty nine sera (98%) from feedlot cattle with VN titers of 1:2 to 1:128 had positive S/N values (< 0.8). One serum with a VN titer of 1:2 had a borderline (+/-) S/N value of 0.81. After immunization with a commercial gIII-positive IBRV vaccine, 115/116 sera with VN titers of 1:2 to 1:256 had positive S/N values (< 0.8). One serum with a VN titer of 1:2 had a negative S/N value of 0.83. Serum from one vaccinated animal that failed to seroconvert after vaccination (VN < 1:4) showed a strongly positive ELISA S/N of 0.48.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331160      PMCID: PMC7119712          DOI: 10.1016/0166-0934(92)90006-y

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  22 in total

1.  Experimental infection of rabbits with the virus of infectious bovine rhinotracheitis.

Authors:  D F Kelly
Journal:  Br J Exp Pathol       Date:  1977-04

2.  Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.

Authors:  M Kit; S Kit; S P Little; R D Di Marchi; C Gale
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

3.  Temporal control of bovine herpesvirus 1 glycoprotein synthesis.

Authors:  G V Ludwig; G J Letchworth
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  A single dilution enzyme-linked immunosorbent assay for the quantitative detection of antibodies to bovine herpesvirus type 1.

Authors:  J K Collins; G A Bulla; C A Riegel; A C Butcher
Journal:  Vet Microbiol       Date:  1985-01       Impact factor: 3.293

Review 5.  Eradication of infectious bovine rhinotracheitis in Switzerland: review and prospects.

Authors:  M Ackermann; H K Müller; L Bruckner; U Kihm
Journal:  Vet Microbiol       Date:  1990-06       Impact factor: 3.293

6.  Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle.

Authors:  D L Hutchings; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Bovine naturally cytolytic cell activation against bovine herpes virus type 1-infected cells does not require late viral glycoproteins.

Authors:  C G Cook; G J Letchworth; G A Splitter
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

8.  Determination of ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus-1 to cause abortion in cattle.

Authors:  J M Miller; C A Whetstone; L J Bello; W C Lawrence
Journal:  Am J Vet Res       Date:  1991-07       Impact factor: 1.156

9.  Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.

Authors:  M Kit; S Kit
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

10.  Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.

Authors:  S Kit; Y Awaya; H Otsuka; M Kit
Journal:  J Vet Diagn Invest       Date:  1990-01       Impact factor: 1.279

View more
  2 in total

1.  Diagnostic potential of anti-rNcp-43 polyclonal antibodies for the detection of Neospora caninum.

Authors:  Gizele Lima de Sá; Diene de Borba Pacheco; Leonardo Garcia Monte; Francine Alves Sinnott; Marina Amaral Xavier; Caroline Rizzi; Sibele Borsuk; Maria Elisabeth Aires Berne; Renato Andreotti; Cláudia Pinho Hartleben
Journal:  Curr Microbiol       Date:  2013-12-06       Impact factor: 2.188

2.  Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus.

Authors:  Xuesong Li; Guoxin Li; Qiaoyang Teng; Lei Yu; Xiaogang Wu; Zejun Li
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.